JOHNSON & JOHNSON (JNJ) 168.23 -0.66 (-0.39%)
168.23 -0.66 (-0.39%)
US4781601046 - Common Stock - After market: 168.1 -0.13 (-0.08%)
Buy % Consensus
Analysts have set a mean price target of 188.75. This target is 12.2% above the current price.
JNJ was analyzed by 27 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about JNJ.
In the previous month the buy percentage consensus was at a similar level.
JNJ was analyzed by 27 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target
Up and Down Grades
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-01-25 | Atlantic Equities | Maintains | Neutral |
| 2023-01-25 | Morgan Stanley | Maintains | Equal-Weight |
| 2023-01-20 | SVB Leerink | Maintains | Outperform |
| 2022-12-12 | Citigroup | Maintains | Buy |
| 2022-12-06 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-12-01 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-11-18 | Credit Suisse | Initiate | Neutral |
| 2022-10-19 | Atlantic Equities | Maintains | Neutral |
| 2022-10-19 | Raymond James | Maintains | Outperform |
| 2022-10-19 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-10-18 | Barclays | Initiate | Equal-Weight |
| 2022-10-12 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-09-12 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-07-21 | UBS | Maintains | Neutral |
| 2022-07-20 | Atlantic Equities | Maintains | Neutral |
| 2022-07-20 | SVB Leerink | Maintains | Outperform |
| 2022-07-20 | Raymond James | Maintains | Outperform |
| 2022-07-20 | Citigroup | Maintains | Buy |
| 2022-07-13 | Wells Fargo | Maintains | Overweight |
| 2022-07-08 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-05-17 | Citigroup | Maintains | Buy |
| 2022-04-20 | Raymond James | Maintains | Outperform |
| 2022-04-20 | Credit Suisse | Maintains | Outperform |
| 2022-04-20 | Citigroup | Maintains | Buy |
| 2022-04-14 | Raymond James | Maintains | Outperform |
| 2022-04-12 | Goldman Sachs | Maintains | Neutral |
| 2022-01-26 | Raymond James | Maintains | Outperform |
| 2022-01-24 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-12-17 | Goldman Sachs | Initiate | Neutral |
| 2021-10-20 | Raymond James | Maintains | Outperform |
Analyst Ratings Stock Screener Links
Best Analyst Rating Competitors Stock Screener
Find the competitors with the best analyst ratings on the USA